A case report on the atypical metastatic pathway of prostate cancer to the kidney and stomach
Jhe‐Yuan Hsu(Tungs' Taichung MetroHarbor Hospital), Min‐Che Tung(National Chung Hsing University), Yen‐Chuan Ou(Tungs' Taichung MetroHarbor Hospital), Lihua Huang(Central South University), Hong-Wei Gao(Tri-Service General Hospital), Yi‐Sheng Lin(Peking University), Chao‐Yu Hsu(National Chung Hsing University), Wei‐Chun Wen(Tungs' Taichung MetroHarbor Hospital)
Cited by 1
Related Papers
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Oncology|2020|502
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
|European Urology|2006|176
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
|European Urology|2010|154
Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy
|British Journal of Urology|2010|141